References
1. Tsui JL, Estrada OA, Deng Z, et al. Analysis of pulmonary features
and treatment approaches in the COPA syndrome. ERJ Open Res .
2018;4(2):00017-02018. doi:10.1183/23120541.00017-2018
2. Almeida de Jesus A, Goldbach-Mansky R. Newly recognized mendelian
disorders. Curr Opin Rheumatol . 2015;27:511-519.
doi:10.1097/BOR.0000000000000207
3. Vece TJ, Watkin LB, Nicholas SK, et al. Copa Syndrome: a Novel
Autosomal Dominant Immune Dysregulatory Disease. J Clin Immunol .
2016;36(4):377-387. doi:10.1007/s10875-016-0271-8
4. Watkin LB, Jessen B, Wiszniewski W, et al. COPA mutations impair
ER-Golgi transport and cause hereditary autoimmune-mediated lung disease
and arthritis. Nat Genet . 2015. doi:10.1038/ng.3279
5. COATOMER PROTEIN COMPLEX, SUBUNIT ALPHA; COPA. 601924. Online
Mendelian Inheritance in Man, OMIMĀ®. https://omim.org/. Published 2015.
6. Volpi S, Tsui J, Mariani M, et al. Type I interferon pathway
activation in COPA syndrome. Clin Immunol . 2018;187:33-36.
doi:10.1016/j.clim.2017.10.001
7. Noorelahi R, Perez G, Otero HJ. Imaging findings of Copa syndrome in
a 12-year-old boy. Pediatr Radiol . 2018;48(2):279-282.
doi:10.1007/s00247-017-3961-3
8. Jensson BO, Hansdottir S, Arnadottir GA, et al. COPA syndrome in an
Icelandic family caused by a recurrent missense mutation in COPA.BMC Med Genet . 2017. doi:10.1186/s12881-017-0490-8
9. Prenzel F, Harfst J, Schwerk N, et al. Lymphocytic interstitial
pneumonia and follicular bronchiolitis in children: A registry-based
case series. Pediatr Pulmonol . 2020;55(4):909-917.
doi:10.1002/ppul.24680